Dasatinib N-Oxide

• CAT Number: R010130
• CAS Number: 910297-52-8
• Molecular Formula: C22H26ClN7O3S
• Molecular Weight: 504.006
• Purity: ≥95%
• Synonyms: N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide N-Oxide
• Target: Drug Metabolite
• Storage: -20°C
• IUPAC Name: N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-4-oxidopiperazin-4-ium-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
• InChI: InChI=1S/C22H26ClN7O3S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(34-17)27-18-12-19(26-15(2)25-18)29-6-8-30(33,9-7-29)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)
• InChIKey: UEFNEEZCTQCRAW-UHFFFAOYSA-N
• SMILES: CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CC[N+](CC4)(CCO)[O-])C

Dasatinib N-Oxide (Cat.No:R010130) is a derivative of Dasatinib, a tyrosine kinase inhibitor used in cancer therapy. This compound may exhibit altered pharmacological properties compared to Dasatinib. Research on Dasatinib N-Oxide aims to explore its potential as an anticancer agent with modified efficacy or reduced side effects.